Clearstead Trust’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.32M | Sell |
13,194
-344
| -3% | -$74K | 0.43% | 39 |
|
|
2026
Q1 | $2.94M | Sell |
13,538
-135
| -1% | -$29.9K | 0.48% | 37 |
|
|
2025
Q4 | $3.12M | Sell |
13,673
-984
| -7% | -$224K | 0.49% | 35 |
|
|
2025
Q3 | $3.39M | Buy |
14,657
+81
| +0.6% | +$16.5K | 0.58% | 31 |
|
|
2025
Q2 | $2.71M | Buy |
14,576
+2,907
| +25% | +$540K | 0.51% | 32 |
|
|
2025
Q1 | $2.44M | Sell |
11,669
-97
| -0.8% | -$18.9K | 0.54% | 32 |
|
|
2024
Q4 | $2.09M | Sell |
11,766
-452
| -4% | -$83.1K | 0.45% | 38 |
|
|
2024
Q3 | $2.41M | Sell |
12,218
-551
| -4% | -$103K | 0.58% | 30 |
|
|
2024
Q2 | $2.19M | Sell |
12,769
-1,320
| -9% | -$219K | 0.54% | 33 |
|
|
2024
Q1 | $2.57M | Sell |
14,089
-1,032
| -7% | -$178K | 0.67% | 28 |
|
|
2023
Q4 | $2.34M | Sell |
15,121
-2,014
| -12% | -$294K | 0.64% | 29 |
|
|
2023
Q3 | $2.55M | Sell |
17,135
-22
| -0.1% | -$3.23K | 0.84% | 23 |
|
|
2023
Q2 | $2.35M | Buy |
17,157
+576
| +3% | +$84.5K | 0.75% | 24 |
|
|
2023
Q1 | $2.64M | Sell |
16,581
-572
| -3% | -$87.4K | 0.84% | 25 |
|
|
2022
Q4 | $2.77M | Buy |
17,153
+379
| +2% | +$58.1K | 0.92% | 24 |
|
|
2022
Q3 | $2.25M | Buy |
16,774
+15,491
| +1,207% | +$2.22M | 0.78% | 26 |
|
|
2022
Q2 | $197K | Hold |
1,283
| – | – | 0.15% | 78 |
|
|
2022
Q1 | $208K | Sell |
1,283
-78
| -6% | -$11.3K | 0.13% | 84 |
|
|
2021
Q4 | $184K | Hold |
1,361
| – | – | 0.11% | 93 |
|
|
2021
Q3 | $147K | Buy |
1,361
+617
| +83% | +$70.5K | 0.09% | 102 |
|
|
2021
Q2 | $84K | Buy |
+744
| New | +$83.8K | 0.05% | 108 |
|
|
2021
Q1 | – | Sell |
-744
| Closed | -$80K | – | 96 |
|
|
2020
Q4 | $80K | Hold |
744
| – | – | 0.05% | 121 |
|
|
2020
Q3 | $65K | Hold |
744
| – | – | 0.05% | 113 |
|
|
2020
Q2 | $73K | Hold |
744
| – | – | 0.06% | 111 |
|
|
2020
Q1 | $57K | Hold |
744
| – | – | 0.05% | 122 |
|
|
2019
Q4 | $66K | Sell |
744
-56
| -7% | -$4.65K | 0.05% | 128 |
|
|
2019
Q3 | $61K | Hold |
800
| – | – | 0.05% | 125 |
|
|
2019
Q2 | $58K | Hold |
800
| – | – | 0.05% | 125 |
|
|
2019
Q1 | $65K | Sell |
800
-1,192
| -60% | -$97.5K | 0.05% | 124 |
|
|
2018
Q4 | $184K | Hold |
1,992
| – | – | 0.17% | 96 |
|
|
2018
Q3 | $188K | Sell |
1,992
-2,100
| -51% | -$199K | 0.14% | 93 |
|
|
2018
Q2 | $379K | Buy |
4,092
+1,992
| +95% | +$195K | 0.34% | 69 |
|
|
2018
Q1 | $199K | Sell |
2,100
-367
| -15% | -$40.3K | 0.17% | 94 |
|
|
2017
Q4 | $239K | Hold |
2,467
| – | – | 0.16% | 97 |
|
|
2017
Q3 | $219K | Hold |
2,467
| – | – | 0.16% | 108 |
|
|
2017
Q2 | $179K | Buy |
2,467
+1,667
| +208% | +$112K | 0.14% | 101 |
|
|
2017
Q1 | $52K | Hold |
800
| – | – | 0.04% | 119 |
|
|
2016
Q4 | $50K | Buy |
+800
| New | +$48.8K | 0.04% | 118 |
|
Other funds holding ABBV
Clearstead Trust's ABBV Position: Q2 2026 in Review
Clearstead Trust reduced its AbbVie (ABBV) stake by 2.5% in Q2 2026, selling an estimated $74K and leaving 13,194 shares worth $3.32M. The position accounts for 0.43% of the portfolio, ranked #39.
Clearstead Trust first reported a position in ABBV in Q4 2016 and has held it in 38 quarters since. The position peaked at $3.39M in Q3 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Clearstead Trust held 13,194 shares of AbbVie worth $3.32M as of Q2 2026.
- Clearstead Trust sold 344 AbbVie shares in Q2 2026, an estimated $74K.
- AbbVie made up 0.43% of Clearstead Trust's portfolio in Q2 2026, its #39 holding.
- Clearstead Trust first reported a position in AbbVie in Q4 2016 and has held it in 38 quarters since.
- Clearstead Trust's AbbVie position peaked at $3.39M in Q3 2025.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.